MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
COSM Cosmos Health
- 0.5829
- -0.0360-5.82%
Close Dec 20 16:00 ET
- 0.5875
- +0.0046+0.79%
Post 16:04 ET
13.56MMarket Cap-0.24P/E (TTM)
0.6477High0.5829Low160.46KVolume0.6400Open0.6189Pre Close96.65KTurnover0.92%Turnover RatioLossP/E (Static)23.26MShares1.650052wk High0.39P/B10.20MFloat Cap0.467752wk Low--Dividend TTM17.49MShs Float194.2500Historical High--Div YieldTTM10.47%Amplitude0.4677Historical Low0.6020Avg Price1Lot Size
About Cosmos Health Company
Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.
Company Profile
SymbolCOSM
Company NameCosmos Health
Listing DateFeb 28, 2022
Founded2009
CEOMr. Grigorios Siokas
MarketNASDAQ
Employees125
Fiscal Year Ends12-31
Address5 Agiou Georgiou Street,Pilea
CityThessaloniki
ProvinceCentral Macedonia
CountryGreece
Zip Code554 38
Phone30-312-865-0026
Company Executives
- Name
- Position
- Salary
- Grigorios Siokas
- Chief Executive Officer and Chairman of the Board; Chief Executive Officer and Operations Manager of SkyPharm SA
- 2.80M
- Nikolaos Bardakis
- Chief Operating Officer
- 47.81K
- Georgios Terzis
- Chief Financial Officer and Principal Accounting Officer
- 435.48K
- Suhel Bhutawala
- Director and Managing Director of Decahedron Ltd
- 83.40K
- John J. Hoidas
- Independent Director
- 32.65K
- Dr. Anastasios Aslidis, M.S.,PhD
- Independent Director
- 130.60K
- Dr. Manfred Ziegler
- Independent Director
- 30.15K
- Demetrios G. Demetriades
- Independent Director
- 32.65K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.